National Healthcare Properties, Inc. (NHP) AI Stock Analysis
NHP AI stock analysis summary
AI ResearchNational Healthcare Properties, Inc. (NHP) is a self-managed healthcare REIT primarily focused on senior housing. The company generated $344.3M in trailing twelve-month revenue, but recorded a profit margin of -13.0% and an operating margin of 10.3%. Its balance sheet reflects $302.4M in cash against $861.0M in total debt as of June 30, 2026.
- Market cap
- $1.10B
- Revenue (TTM)
- $344.3M
- P/E
- —
- 1Y return
- — S&P 500 16.8%
- Avg. target
- $19.25 27.4% vs last close
Bull case
- The mean analyst price target of $19.25 sits 27.4% above the last closing price of $15.11.
- Analyst estimates forecast next fiscal year revenue to expand by 19.3% to $432.2M.
- Trailing twelve-month operating margin improved to 10.3%, up from 1.0% in FY2025 and -34.9% in FY2024.
Bear case
- Net income remained in deficit for four consecutive fiscal years, ending at -$57.6M in FY2025.
- Free cash flow in FY2025 was -$21.8M, following -$101.8M in FY2024.
- Total debt reached $861.0M as of June 30, 2026, leaving net debt at $558.6M against $302.4M in cash.
What National Healthcare Properties does
National Healthcare Properties, Inc. is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate. The company places an emphasis on providing senior housing to serve a growing elderly population in the United States. Incorporated in 2012 in Maryland, USA, National Healthcare Properties operates with 31 employees and is listed on the NASDAQ exchange.
Growth and profitability
Between FY2022 and FY2025, revenue grew at a 3-year CAGR of 0.6%, moving from $335.8M in FY2022 to $345.9M in FY2023 and $353.8M in FY2024, before revenue fell 3.3% to $342.3M in FY2025. Gross margin was 36.0% in FY2025, and operating margin recovered to 1.0% following -34.9% in FY2024. Net income remained negative across all reported years, standing at -$57.6M in FY2025 compared to -$189.7M in FY2024. In the trailing twelve months, revenue reached $344.3M with an operating margin of 10.3% and a profit margin of -13.0%. For the latest quarter ended June 30, 2026, quarterly revenue growth was 2.6% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, the company held $302.4M in cash and short-term investments against total debt of $861.0M, resulting in net debt of $558.6M. Shareholders' equity was $1.05B and total assets were $1.98B, yielding a debt-to-equity ratio of 0.82 and a current ratio of 1.00. In FY2025, operating cash flow was $7.0M, while free cash flow was -$21.8M. During that fiscal year, capital expenditures were $28.7M, share buybacks totaled $5.4M, and dividends paid were $13.4M.
Valuation and performance
National Healthcare Properties carries a market capitalization of $1.10B and an enterprise value of $1.79B. Its price-to-sales ratio of 3.2x is below the 3.7x median of its US-listed Real Estate peers. Its enterprise value to EBITDA ratio of 21.1x trades at a premium to the peer group median of 14.7x, while its price-to-book ratio is 1.1x. In comparison, the S&P 500 (SPY) returned 16.8% over the past year and 83.0% over five years. As of October 16, 2026, the stock closed at $15.11, between its 52-week low of $11.25 and 52-week high of $17.46.
NHP dividend
National Healthcare Properties pays an annual forward dividend of $0.30, providing a dividend yield of 1.99%. The distribution follows a Quarterly schedule with a payout ratio of 2.2%. The stock's last ex-dividend date was October 9, 2026.
What analysts expect
Analyst coverage consists of 3 Strong Buy, 2 Buy, and 4 Hold ratings, with 0 Sell and 0 Strong Sell ratings. The mean price target of $19.25 implies a 27.4% premium over the last close of $15.11. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $362.2M and EPS of $0.20. For the next fiscal year, 2 analysts project revenue of $432.2M and an EPS estimate of -$0.01. The next earnings date is November 4, 2026.
Key risks and what to watch
- A trailing twelve-month profit margin of -13.0% and return on equity of -5.3% indicate continuing net losses.
- Consensus models an EPS decline of 104.9% in the next fiscal year to -$0.01, reversing the current fiscal year EPS estimate of $0.20.
- The company's quarterly revenue growth year-over-year of 2.6% lags the 4.6% median of its US-listed Real Estate peers.
- Short interest stands at 7.6% of the float as of October 16, 2026.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this NHP AI stock analysis
This page is an AI-written research summary of National Healthcare Properties, Inc. (NHP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: NHP income statement, NHP balance sheet, NHP key metrics, NHP analyst forecast, NHP chart. See the NHP stock overview for the latest quote and news.
NHP AI stock analysis FAQ
Does NHP pay a dividend?
Yes. National Healthcare Properties pays a Quarterly dividend with an annual forward rate of $0.30 per share, representing a dividend yield of 1.99% and a payout ratio of 2.2%.
What is NHP's debt and liquidity position?
As of June 30, 2026, the company held $302.4M in cash and short-term investments and $861.0M in total debt, resulting in net debt of $558.6M. Its debt-to-equity ratio was 0.82 and its current ratio was 1.00.
What is the consensus price target for NHP?
Analysts have a mean price target of $19.25, which is 27.4% above the last closing price of $15.11 on October 16, 2026. The stock has 3 Strong Buy, 2 Buy, and 4 Hold ratings.
When is NHP's next earnings report?
The next earnings date is November 4, 2026. For the current fiscal year ending December 31, 2026, analysts estimate revenue of $362.2M and EPS of $0.20.